1. Field
The present invention relates generally to medical imaging systems, and more particularly to a method and apparatus for evaluating regurgitation of blood from heart valves.
2. Background
Regurgitation, or the backward flow of blood through a defective heart valve, is a critical measurement used quite extensively in cardiology. Ideally, all the blood that is passed from one chamber of the heart to another chamber gets pumped out by the second chamber. Valves in the heart should prevent the flow of blood from a succeeding chamber back to a preceding chamber. For example, a mitral valve between the left atrium chamber of the heart stops flow back into the left ventricle chamber of the heart. However, in some diseased hearts, the valves operation might not be optimal. In such cases some amount of regurgitation, or back-flow, exists from a higher pressure succeeding chamber to a lower pressure preceding chamber.
Ultrasound devices have been developed and refined for the diagnosis and treatment of various medical conditions. Such devises have been developed, for example, to track the magnitude and direction of moving objects, or the position of moving objects over time. By way of example, Doppler echocardiography is one ultrasound technique that is used to determine information about the motion of blood and tissue for the diagnosis and treatment of cardiac conditions. In echocardiography the motion information is obtained from recordings and measurements of Doppler data.
The Doppler principle, as used in Doppler echocardiography, is well known and generally involves exploiting an observed phenomenon that the frequency of reflected ultrasound pulses is altered by a moving object, such as moving tissue or blood cells. This alteration, or change, in frequency is generally referred to as a Doppler shift, with the magnitude of the frequency change, or Doppler shift, being related to the velocity of the moving object form which the ultrasound pulses are reflected. The polarity of the frequency change, or Doppler shift, is related to the direction of motion relative to the ultrasound source: a positive frequency shift (increase) indicates the motion is towards the ultrasound sensor and a negative frequency shift (decrease) indicates that the motion is away from the ultrasound sensor. As such, the magnitude and polarity of the Doppler shift can be used to track the magnitude and direction of moving objects.
Intra-cardiac ultrasonic imaging, a technique where a steerable catheter fitted with an ultrasound transducer on its tip is used to view the interior anatomy of a beating heart has significantly improved the definition and clarity of views of diseased valves. However, a drawback to intra-cardiac ultrasound imaging is the need to account for a field of view which is constantly in motion. Furthermore, given the dynamics of an interventional cardiology procedure, where intra-cardiac ultrasound is predominantly employed, an imaging catheter could also be in constant motion due to blood flow. This can cause measurements difficulties, due to the dynamic qualities involved, such as the dynamics of the field of view and the catheter. In addition, the position of the ultrasound imaging head, or transducer, can be restricted to fields of view where the blood flow across a valve being studied is close to orthogonal to the ultrasound beam, where existing Doppler techniques have difficulty operating. It is also desirable, in many cases, to assign a quantitative value, or number, to regurgitation measurements and associated abnormal flow patterns, including turbulence.
Thus, a need exists for improved measurement and quantification of heart valve regurgitation.
Embodiments disclosed herein address the above stated needs by providing methods and apparatus for improving measurement and quantification of regurgitation. The techniques monitor flow across a valve and evaluate regurgitation through the valve. Monitoring the flow may be performed either semi-automatically or automatically. Techniques to assess the flow even in the case where the flow across the valve is orthogonal to the imaging-line from the transducer are also disclosed. The techniques can be used with Doppler data collected using an ultrasound transducer attached to a steerable catheter used to view the interior anatomy of a heart to perform intra-cardiac ultrasonic imaging.
In one embodiment an ultrasound scanner with Doppler capabilities processes and represents Doppler signal data in a color scale. The color scale can be determined in many different ways, for example through a functionality similar to a “look-up table.” The Doppler signal data is processed such that different colors are assigned to the signal based on its power level. For example, different power levels in the processed signal may be represented in two or more colors. The color scale may be either dynamically generated or previously set up in the system through any combination of hardware or software.
An ultrasound scanner system may also capture and display an electrocardiogram (ECG) of a patient as well. In such a system, signals from blood, which can be identified by their received power levels and corresponding color, may be tracked. Depending upon the angle between the blood flow and the ultrasound beam, blood flow in the reverse direction (regurgitation) may be determined, or estimated, for example, by utilizing correlation with the ECG to determine phases of the cardiac cycle. Tracking techniques may be applied to locate peak flows in either direction and the total flow in either direction may be determined, or estimated, per cardiac cycle to provide a numerical estimate of regurgitation. In cases where the blood flow is orthogonal to the line of interrogation of the ultrasound, the overall bandwidth of the resulting Doppler signal is ascertained, again using the power levels to differentiate between tissue and blood, and the peak bandwidth at various points along the cardiac cycle are estimated and thus an estimation of regurgitation is obtained. Alternatively, in another embodiment, such bandwidth based estimates can also be used to judge overall turbulence in flow, such as flow in the atrial appendage etc. In another embodiment, a user can indicate, either on the ECG or on the Doppler spectrum, an area of interest where reverse flow through the valve is to be determined or estimated.
In yet another embodiment, a user may outline an area in a Color Doppler image pertaining to flow around a valve. In such a case, the base-line adjusted color Doppler representation of flow through a valve is captured as a color image. The relative width of the reverse flow, which can be denoted by a different color to that of normal flow through the valve, may then be measured as an area and translated to volumetric flow assuming a conical volume extrapolation or such other area to volume extrapolated fit. The translation may be performed automatically.
Other features and advantages of the present invention should be apparent from the following description of exemplary embodiments, which illustrate, by way of example, aspects of the invention.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments.
Some difficulties can be presented by intra-cardiac ultrasonic imaging, including the need to account for a field of view which is constantly in motion. The imaging catheter could be in constant motion due to blood flow, and the position of the ultrasound imaging head, or transducer, can be restricted to fields of view where the blood flow across a valve being studied is close to orthogonal to the ultrasound beam. Some of the issues raised by a field of view that is constantly in motion, along with limitations of operator interaction in a practical interventional cardiology application, are addressed in co-pending U.S. patent application Ser. No. 11/302,391, entitled METHOD AND SYSTEM FOR ENHANCING SPECTRAL DOPPLER PRESENTATION, filed Dec. 14, 2005, assigned to the assignee of the present application and hereby incorporated herein in its entirety.
In co-pending U.S. patent application Ser. No. 11/302,391, techniques are described for displaying Doppler spectral data, wherein Doppler signals from any strong reflectors, such as tissue, within the sample volume are shown in a different color than signals from weaker reflectors, such as blood. Such a differentiation is obtained by displaying frequency components with different amplitudes, or power levels, in different colors.
Techniques are described below to improve the measurement and quantification of regurgitation. Techniques of monitoring flow across a valve and evaluating regurgitation through the valve either semi-automatically or automatically are described. Techniques to assess flow across a valve and evaluate regurgitation, even in the case where the flow across the valve is orthogonal to the imaging-line from the transducer, are also described. The techniques described include both semi-automated, and fully-automated estimation of regurgitation. Also, estimating regurgitation can be done real-time, when the data is being acquired, or off-line, that is, storing ultrasound data and processing it later.
As shown in
In this example the ultrasound is “range gated” so that only the region of interest 120 around the heart valve leaflets 106, and the surrounding blood 108, are examined. Thus, the region of the sector 102 that the ultrasound beam 112 passes through before and after the area of interest, 122 and 124 respectively, are not examined and not displayed in the Doppler presentation.
Doppler signals may be obtained from the area of interest 122 that includes a valve being evaluated wherein a relevant majority of the cross-section of the valve is included within the area of interest 120. As described in co-pending U.S. patent application Ser. No. 11/302,391, the signals may be processed to distinguish signals received from blood from those received from tissue, and then different colors may be assigned to the different signals. The signals can then be processed in different ways to obtain regurgitation. For example, the processed Doppler signals can be correlated to an ECG signal to determine systole and diastole of the heart. The peak reverse flow at systole, such as in the case with interrogation of the atrio-ventricular valves, may then be measured. In another example, peak forward and reverse flow may be measured during a given cardiac cycle, where the cardiac cycle is identified by a periodic repetition of a peak value, or a pattern of flow, or a positive to negative flow translation in a given direction. Regurgitation may then be estimated using the ratio of reverse flow as a percentage of forward flow. The forward and reverse flows are given by the area under the respective forward flow and reverse flow curves, normalized for the angle between the ultrasound beam and the blood flow.
Also included in
It is noted that the spectral Doppler information can be obtained from the ultrasonic interrogation device either as a spectrum, that is digitized line data as a function of time, or digitized images, or the Doppler information may be obtained as an audio signal output which is subsequently digitized and processed to obtain a velocity-time profile Doppler display 202.
In cases where color Doppler is the mode of interrogation, various frames, or a sampling of frames, that form a real time image may be analyzed as a function of the ECG 220, with the ECG being utilized to denote the phases of the cardiac cycle. In such an application, the presence or absence of a particular color, and hence directional flow, as indicated by the Doppler display 202 during a particular phase of the cardiac cycle, can be detected. Also, the number of pixels in the Doppler display that are assigned a particular color and the duration of persistence of that color through the cardiac cycle provides additional information regarding regurgitation.
For example, consider the case where the valve is being imaged from the atrium, with backflow from the valve being directed straight at the transducer, and the color code for blood flow towards the transducer is graduated in a color scale from red to yellow for increasing velocity up to, for example, 0.8 m/sec. At systole, the display portion 230 showing regurgitation appears as a red/yellow colored flow emanating out of the atrio-ventricular valve in question. By compensating for angle between the ultrasound beam and the blood flow, the color scale can be recalibrated to more accurately depict the velocity. Knowledge of the imaging frame rate, or sub-sampling rate if a framegrabber or other video capture device is employed to obtain these images, and knowledge of the cardiac cycle (start of systole), can be used to determine the velocity profile of peak flow velocity through the valve as a function of time. The end of this cycle may be considered either as a function of the ECG, or when flow towards the transducer has stopped. Similarly, flow away from the transducer 240 can be analyzed to provide a time-velocity profile. Regurgitation can be calculated from the time-velocity profile as described in the case of spectral-Doppler.
In conditions when the blood flow is nearly perpendicular to the interrogating ultrasound beam, as illustrated in
The techniques described can be implemented in many different systems.
The ultrasound scanner 504 generates signals that are communicated to the ultrasonic transducer 506. The ultrasonic transducer transmits signals and receives reflected signals from a desired sample 522, for example from a human heart tissue and blood. Signals received by the ultrasonic transducer 506 are communicated to the ultrasound scanner 504. In one embodiment, the ultrasound scanner 504 processes the received signals, including color mapping, and the processed signal is provided to the display 508 for presentation to a user. In another embodiment, the ultrasound scanner 504 processes the received signal and the display 508 includes a processor that processes the signal, for example to perform color mapping, before presentation to a user. Determining regurgitation can be performed in the ultrasound scanner 504, a processor associated with the display 508, or both.
In general, the ultrasound scanner 504 includes a combination of digital or analog electronics capable of generating necessary signals and processing such received signals so as to generate Doppler representations and determine regurgitation in accordance with the invention. In addition, processing of the Doppler signals and determining regurgitation may be performed in real-time, that is at the time the signals are captured, or off-line following the capture of the data.
The ultrasonic transducer 506 can include, for example, one or more transducers that utilize piezoelectric properties to generate acoustic signals from electrical signals. The transducer may be a mechanical, sector, linear, or curved array design. In general, the type of transducer used is selected to be appropriate for the particular application such as an external application, trans-oesophageal, intra-vascular, intra-cardiac, or endocavitary applications.
The previous embodiments describe a general Doppler scanner system. A system could also be implemented using a simple ultrasound Doppler processing set up.
Other combinations of hardware and software may be used to perform the techniques described so as to achieve the operationally described. For example, there are multiple ways of interlinking the components that form this invention.
Signals from the structure being imaged are also acquired by an ECG processor 1010. The output of the ECG processor and the Doppler processor 1008 are communicated to an ECG Doppler correlator 1012. The ECG Doppler correlator 1012 correlates the ECG and Doppler information, for example, to determine systole and diastole of the heart. The correlated information is communicated to a velocity-time curve estimator 1014 where estimates of the velocity, speed and direction, versus time are produced. The velocity-time curve estimates are then used in the regurgitation calculation engine 1016. The ECG information, Doppler information, velocity-time curves, and regurgitation calculations may then be presented to a user on a display 1018. It is noted that any combination of the ECG information, Doppler information, velocity-time curves, and regurgitation calculations may be displayed
The system illustrated in
In block 1204 the processed Doppler signals and ECG signals are correlated. Correlating the signals can be used, for example, to judge, or determine, the systole and diastole of a heart. Flow then continues to block 1206 where regurgitation is determined by estimating the peak reverse flow through the heart at systole.
In block 1304 the processed Doppler signals are examined to determine the peak forward and reverse flows during a given cardiac cycle. The cardiac cycle may be determined in numerous ways. For example, the cardiac cycle may be determined by the periodic repetition of a peak value, or a pattern of flow, or a positive to negative transition in a given direction. Flow then continues to block 1306 where regurgitation is determined as the ratio of the reverse flow as a percentage of the forward flow. The forward and reverse flows can be determined in various ways. For example the forward and reverse flows can be estimated by determining the area under the respective forward and reverse flow curves of the Doppler signals. It is beneficial to normalize, or correct, the flow curves according to the angle between the ultrasound beam and the direction of the blood flow.
Each step in the above flow, of determining the phases of the cardiac cycle, of detecting the peak flow velocities, and of judging the angle, can be performed automatically through appropriate processing on a computer, or can be manually performed by the user through the use of one or more user interface techniques, such as demarcating the point on a screen using a mouse or mouse button combination etc.
Those of skill in the art will understand that information and signals may be represented using any of a variety of different technologies and techniques. For example, data, instructions, commands, information, signals, bits, symbols, and chips that may be referenced throughout the above description may be represented by voltages, currents, electromagnetic waves, magnetic fields or particles, optical fields or particles, or any combination thereof.
Those of skill in the art will further appreciate that the various illustrative modules, circuits, and algorithms described may be implemented as electronic hardware, computer software, or combinations of both. Also, the various modules and circuits described may be implemented or performed with a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor may be a microprocessor, any conventional processor, controller, or micro controller. A processor may also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. Software modules may reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Number | Name | Date | Kind |
---|---|---|---|
4161121 | Zitelli et al. | Jul 1979 | A |
4241610 | Anderson | Dec 1980 | A |
4462408 | Silverstein et al. | Jul 1984 | A |
4519260 | Fu et al. | May 1985 | A |
4576177 | Webster, Jr. | Mar 1986 | A |
4605009 | Pourcelot et al. | Aug 1986 | A |
4841977 | Griffith et al. | Jun 1989 | A |
4890268 | Smith et al. | Dec 1989 | A |
4917097 | Proudian et al. | Apr 1990 | A |
4951677 | Crowley et al. | Aug 1990 | A |
5002059 | Crowley et al. | Mar 1991 | A |
5090956 | McCoy | Feb 1992 | A |
5105819 | Wollschlager et al. | Apr 1992 | A |
5152294 | Mochizuki et al. | Oct 1992 | A |
5158087 | Gatzke | Oct 1992 | A |
5170793 | Takano et al. | Dec 1992 | A |
5195968 | Lundquist et al. | Mar 1993 | A |
5254088 | Lundquist et al. | Oct 1993 | A |
5279559 | Barr | Jan 1994 | A |
5307816 | Hashimoto et al. | May 1994 | A |
5309914 | Iinuma | May 1994 | A |
5325860 | Seward et al. | Jul 1994 | A |
5336182 | Lundquist et al. | Aug 1994 | A |
5345938 | Nishiki et al. | Sep 1994 | A |
5345940 | Seward et al. | Sep 1994 | A |
5357550 | Asahina et al. | Oct 1994 | A |
5358478 | Thompson et al. | Oct 1994 | A |
5364351 | Heinzelman et al. | Nov 1994 | A |
5372138 | Crowley et al. | Dec 1994 | A |
5385148 | Lesh et al. | Jan 1995 | A |
5395327 | Lundquist et al. | Mar 1995 | A |
5409010 | Beach et al. | Apr 1995 | A |
5438997 | Sieben et al. | Aug 1995 | A |
5456258 | Kondo et al. | Oct 1995 | A |
5456664 | Heinzelman et al. | Oct 1995 | A |
5470350 | Buchholtz et al. | Nov 1995 | A |
5477858 | Norris et al. | Dec 1995 | A |
5499630 | Hiki et al. | Mar 1996 | A |
5515853 | Smith et al. | May 1996 | A |
5515856 | Olstad et al. | May 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5560362 | Sliwa, Jr. et al. | Oct 1996 | A |
5588432 | Crowley | Dec 1996 | A |
5622174 | Yamazaki | Apr 1997 | A |
5662116 | Kondo et al. | Sep 1997 | A |
5697965 | Griffin, III | Dec 1997 | A |
5699805 | Seward et al. | Dec 1997 | A |
5701897 | Sano | Dec 1997 | A |
5704361 | Seward et al. | Jan 1998 | A |
5713363 | Seward et al. | Feb 1998 | A |
5715817 | Stevens-Wright et al. | Feb 1998 | A |
5722403 | McGee et al. | Mar 1998 | A |
5749364 | Sliwa, Jr. et al. | May 1998 | A |
5788636 | Curley | Aug 1998 | A |
5795299 | Eaton et al. | Aug 1998 | A |
5797848 | Marian et al. | Aug 1998 | A |
5800356 | Criton et al. | Sep 1998 | A |
5807324 | Griffin, III | Sep 1998 | A |
5846205 | Curley et al. | Dec 1998 | A |
5888577 | Griffin, III et al. | Mar 1999 | A |
5891088 | Thompson et al. | Apr 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
5916168 | Pedersen et al. | Jun 1999 | A |
5921978 | Thompson et al. | Jul 1999 | A |
5928276 | Griffin, III et al. | Jul 1999 | A |
5931863 | Griffin, III et al. | Aug 1999 | A |
5935102 | Bowden et al. | Aug 1999 | A |
5938616 | Eaton et al. | Aug 1999 | A |
5954654 | Eaton et al. | Sep 1999 | A |
6013072 | Winston et al. | Jan 2000 | A |
6033378 | Lundquist et al. | Mar 2000 | A |
6039693 | Seward et al. | Mar 2000 | A |
6085117 | Griffin, III et al. | Jul 2000 | A |
6144870 | Griffin, III | Nov 2000 | A |
6171248 | Hossack et al. | Jan 2001 | B1 |
6173205 | Griffin, III et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6210333 | Gardner et al. | Apr 2001 | B1 |
6224556 | Schwartz et al. | May 2001 | B1 |
6228028 | Klein et al. | May 2001 | B1 |
6228032 | Eaton et al. | May 2001 | B1 |
6261246 | Pantages et al. | Jul 2001 | B1 |
6293943 | Pansecu et al. | Sep 2001 | B1 |
6306096 | Seward et al. | Oct 2001 | B1 |
6306097 | Park et al. | Oct 2001 | B1 |
6310828 | Mumm et al. | Oct 2001 | B1 |
6358208 | Long et al. | Mar 2002 | B1 |
6360027 | Hossack et al. | Mar 2002 | B1 |
6368275 | Sliwa et al. | Apr 2002 | B1 |
6385489 | Griffin, III et al. | May 2002 | B1 |
6398731 | Mumm et al. | Jun 2002 | B1 |
6423002 | Hossack | Jul 2002 | B1 |
6440488 | Griffin, III et al. | Aug 2002 | B2 |
6443894 | Sumanaweera et al. | Sep 2002 | B1 |
6475148 | Jackson et al. | Nov 2002 | B1 |
6475149 | Sumanaweera | Nov 2002 | B1 |
6482161 | Sumanaweera et al. | Nov 2002 | B1 |
6485455 | Thompson et al. | Nov 2002 | B1 |
6491633 | Krishnan et al. | Dec 2002 | B1 |
6503202 | Hossack et al. | Jan 2003 | B1 |
6517488 | Hossack | Feb 2003 | B1 |
6527717 | Jackson et al. | Mar 2003 | B1 |
6532378 | Saksena et al. | Mar 2003 | B2 |
6544181 | Buck et al. | Apr 2003 | B1 |
6554770 | Sumanaweera et al. | Apr 2003 | B1 |
6589182 | Loftman et al. | Jul 2003 | B1 |
6605043 | Dreschel et al. | Aug 2003 | B1 |
6607488 | Jackson et al. | Aug 2003 | B1 |
6607528 | Quick et al. | Aug 2003 | B1 |
6612992 | Hossack et al. | Sep 2003 | B1 |
6645147 | Jackson et al. | Nov 2003 | B1 |
6648875 | Simpson et al. | Nov 2003 | B2 |
6709396 | Flesch et al. | Mar 2004 | B2 |
6908434 | Jenkins et al. | Jun 2005 | B1 |
6923768 | Camus et al. | Aug 2005 | B2 |
20030045796 | Friedman | Mar 2003 | A1 |
20030109785 | Buck et al. | Jun 2003 | A1 |
20030158483 | Jackson et al. | Aug 2003 | A1 |
20040097805 | Verard et al. | May 2004 | A1 |
20040127798 | Dala-Krishna et al. | Jul 2004 | A1 |
20040249282 | Olstad | Dec 2004 | A1 |
20040254483 | Zdeblick et al. | Dec 2004 | A1 |
20050203390 | Torp et al. | Sep 2005 | A1 |
Number | Date | Country | |
---|---|---|---|
20070167794 A1 | Jul 2007 | US |